{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T22:42:59Z","timestamp":1789684979930,"version":"4.0.1"},"reference-count":38,"publisher":"Impact Journals, LLC","issue":"47","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2016,11,22]]},"DOI":"10.18632\/oncotarget.10428","type":"journal-article","created":{"date-parts":[[2016,7,6]],"date-time":"2016-07-06T18:21:55Z","timestamp":1467829315000},"page":"76577-76589","source":"Crossref","is-referenced-by-count":16,"title":["Dasatinib modulates sensitivity to pemetrexed in malignant pleural mesothelioma cell lines"],"prefix":"10.18632","volume":"7","author":[{"given":"Valentina","family":"Monica","sequence":"first","affiliation":[{"name":"Department of Oncology, University of Torino, San Luigi Hospital, Orbassano, Torino, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco Lo","family":"Iacono","sequence":"additional","affiliation":[{"name":"Department of Oncology, University of Torino, San Luigi Hospital, Orbassano, Torino, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Bracco","sequence":"additional","affiliation":[{"name":"Department of Oncology, University of Torino, San Luigi Hospital, Orbassano, Torino, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Busso","sequence":"additional","affiliation":[{"name":"Department of Oncology, University of Torino, San Luigi Hospital, Orbassano, Torino, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura Di","family":"Blasio","sequence":"additional","affiliation":[{"name":"Department of Oncology, University of Torino, IRCCS Candiolo, Torino, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Primo","sequence":"additional","affiliation":[{"name":"Department of Oncology, University of Torino, IRCCS Candiolo, Torino, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Peracino","sequence":"additional","affiliation":[{"name":"Department of Clinical and Biological Sciences, University of Torino, San Luigi Hospital, Orbassano, Torino, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Papotti","sequence":"additional","affiliation":[{"name":"Department of Oncology, University of Torino, San Luigi Hospital, Orbassano, Torino, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Scagliotti","sequence":"additional","affiliation":[{"name":"Department of Oncology, University of Torino, San Luigi Hospital, Orbassano, Torino, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2016,7,6]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0140-6736(05)67025-0","article-title":"Malignant mesothelioma","volume":"366","author":"Lake","year":"2005","journal-title":"Lancet"},{"key":"2","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1200\/JCO.2008.19.8523","article-title":"Malignant pleural mesothelioma","volume":"27","author":"Kindler","year":"2009","journal-title":"Journal of clinical oncology"},{"key":"3","doi-asserted-by":"crossref","first-page":"5629","DOI":"10.3390\/ijerph10115629","article-title":"Domestic asbestos exposure: a review of epidemiologic and exposure data","volume":"10","author":"Mowat","year":"2013","journal-title":"International journal of environmental research and public health"},{"key":"4","doi-asserted-by":"crossref","first-page":"293","DOI":"10.2217\/fon.12.14","article-title":"Systemic treatment of malignant pleural mesothelioma","volume":"8","author":"Scagliotti","year":"2012","journal-title":"Future oncology"},{"key":"5","doi-asserted-by":"crossref","first-page":"e40521","DOI":"10.1371\/journal.pone.0040521","article-title":"Molecular resistance fingerprint of pemetrexed and platinum in a long-term survivor of mesothelioma","volume":"7","author":"Sundstrom","year":"2012","journal-title":"PloS one"},{"key":"6","doi-asserted-by":"crossref","first-page":"e63338","DOI":"10.1371\/journal.pone.0063338","article-title":"Thymidylate synthase expression determines pemetrexed targets and resistance development in tumour cells","volume":"8","author":"Lopez-Vivanco","year":"2013","journal-title":"PloS one"},{"key":"7","doi-asserted-by":"crossref","first-page":"3543","DOI":"10.1200\/JCO.2007.15.0375","article-title":"Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer","volume":"26","author":"Park","year":"2008","journal-title":"Journal of clinical oncology"},{"key":"8","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1002\/cncr.22208","article-title":"Squamous cell carcinoma of the lung compared with other histotypes shows higher messenger RNA and protein levels for thymidylate synthase","volume":"107","author":"Scagliotti","year":"2006","journal-title":"Cancer"},{"key":"9","doi-asserted-by":"crossref","first-page":"7547","DOI":"10.1158\/1078-0432.CCR-09-1641","article-title":"Differential Thymidylate Synthase Expression in Different Variants of Large-Cell Carcinoma of the Lung","volume":"15","author":"Papotti","year":"2009","journal-title":"Clinical cancer research"},{"key":"10","doi-asserted-by":"crossref","first-page":"7212","DOI":"10.1038\/onc.2008.326","article-title":"Inhibition of Src tyrosine kinase reverts chemoresistance toward 5-fluorouracil in human pancreatic carcinoma cells: an involvement of epidermal growth factor receptor signaling","volume":"27","author":"Bruns","year":"2008","journal-title":"Oncogene"},{"key":"11","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1177\/1947601910375273","article-title":"A Phosphotyrosine Proteomic Screen Identifies Multiple Tyrosine Kinase Signaling Pathways Aberrantly Activated in Malignant Mesothelioma","volume":"1","author":"Testa","year":"2010","journal-title":"Genes Cancer"},{"key":"12","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1158\/1535-7163.MCT-07-0052","article-title":"Inhibition of c-Src expression and activation in malignant pleural mesothelioma tissues leads to apoptosis, cell cycle arrest, and decreased migration and invasion","volume":"6","author":"Johnson","year":"2007","journal-title":"Molecular cancer therapeutics"},{"key":"13","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1002\/ijc.26188","article-title":"Expression and pharmacological inhibition of thymidylate synthase and Src kinase in nonsmall cell lung cancer","volume":"130","author":"Scagliotti","year":"2012","journal-title":"International journal of cancer"},{"key":"14","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.ccr.2010.04.026","article-title":"Integrative genomic and proteomic analyses identify targets for Lkb1-deficient metastatic lung tumors","volume":"17","author":"Silva","year":"2010","journal-title":"Cancer cell"},{"key":"15","doi-asserted-by":"crossref","first-page":"10299","DOI":"10.1158\/0008-5472.CAN-10-1873","article-title":"Pemetrexed indirectly activates the metabolic kinase AMPK in human carcinomas","volume":"70","author":"Moran","year":"2010","journal-title":"Cancer research"},{"key":"16","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1038\/bjc.2011.400","article-title":"Preclinical emergence of vandetanib as a potent antitumour agent in mesothelioma: molecular mechanisms underlying its synergistic interaction with pemetrexed and carboplatin","volume":"105","author":"Peters","year":"2011","journal-title":"British journal of cancer"},{"key":"17","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1038\/bjc.2011.129","article-title":"Thymidylate synthase as a determinant of pemetrexed sensitivity in non-small cell lung cancer","volume":"104","author":"Nakagawa","year":"2011","journal-title":"British journal of cancer"},{"key":"18","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1097\/JTO.0b013e31825f22ee","article-title":"A phase II study of intermittent sunitinib malate as second-line therapy in progressive malignant pleural mesothelioma","volume":"7","author":"Byrne","year":"2012","journal-title":"Journal of thoracic oncology"},{"key":"19","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1097\/JTO.0b013e31828c2b26","article-title":"Phase 2 study of sorafenib in malignant mesothelioma previously treated with platinum-containing chemotherapy","volume":"8","author":"Spicer","year":"2013","journal-title":"Journal of thoracic oncology"},{"key":"20","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.canlet.2010.07.020","article-title":"RAD001 shows activity against gastric cancer cells and overcomes 5-FU resistance by downregulating thymidylate synthase","volume":"299","author":"Bang","year":"2010","journal-title":"Cancer letters"},{"key":"21","doi-asserted-by":"publisher","first-page":"32622","DOI":"10.18632\/oncotarget.5327","article-title":"Acquired resistance to 5-fluorouracil via HSP90\/Src-mediated increase in thymidylate synthase expression in colon cancer","volume":"6","author":"Lee","year":"2015","journal-title":"Oncotarget"},{"key":"22","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1097\/JTO.0b013e318248242c","article-title":"Phase II study of dasatinib in patients with previously treated malignant mesothelioma (cancer and leukemia group B 30601): a brief report","volume":"7","author":"Kindler","year":"2012","journal-title":"Journal of thoracic oncology"},{"key":"23","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1006\/excr.2001.5451","article-title":"Synergistic activation of the TATA-less mouse thymidylate synthase promoter by the Ets transcription factor GABP and Sp1","volume":"274","author":"Johnson","year":"2002","journal-title":"Experimental cell research"},{"key":"24","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/(SICI)1097-4644(20000401)77:1<50::AID-JCB6>3.0.CO;2-C","article-title":"Transcriptional control elements and complex initiation pattern of the TATA-less bidirectional human thymidylate synthase promoter","volume":"77","author":"Johnson","year":"2000","journal-title":"Journal of cellular biochemistry"},{"key":"25","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.canlet.2012.04.022","article-title":"Second-generation tyrosine kinase inhibitors reduce telomerase activity in K562 cells","volume":"323","author":"Shpilberg","year":"2012","journal-title":"Cancer letters"},{"key":"26","doi-asserted-by":"crossref","first-page":"4762","DOI":"10.1158\/0008-5472.CAN-13-3627","article-title":"Combined SFK\/mTOR inhibition prevents rapamycin-induced feedback activation of AKT and elicits efficient tumor regression","volume":"74","author":"Keri","year":"2014","journal-title":"Cancer research"},{"key":"27","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.18632\/oncotarget.1760","article-title":"Rapamycin downregulates thymidylate synthase and potentiates the activity of pemetrexed in non-small cell lung cancer","volume":"5","author":"Dennis","year":"2014","journal-title":"Oncotarget"},{"key":"28","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1158\/2159-8290.CD-13-0015","article-title":"Metabolic and functional genomic studies identify deoxythymidylate kinase as a target in LKB1-mutant lung cancer","volume":"3","author":"Driggers","year":"2013","journal-title":"Cancer discovery"},{"key":"29","doi-asserted-by":"publisher","first-page":"584","DOI":"10.18632\/oncotarget.965","article-title":"Dysfunctional oxidative phosphorylation makes malignant melanoma cells addicted to glycolysis driven by the (V600E)BRAF oncogene","volume":"4","author":"Christensen","year":"2013","journal-title":"Oncotarget"},{"key":"30","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1093\/carcin\/bgs109","article-title":"Deficiency of Fyn protein is prerequisite for apoptosis induced by Src family kinase inhibitors in human mesothelioma cells","volume":"33","author":"Fujimori","year":"2012","journal-title":"Carcinogenesis"},{"key":"31","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.3892\/or.2012.2010","article-title":"Yes is a central mediator of cell growth in malignant mesothelioma cells","volume":"28","author":"Yano","year":"2012","journal-title":"Oncology reports"},{"key":"32","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.abb.2014.11.008","article-title":"Dasatinib enhances cisplatin sensitivity in human esophageal squamous cell carcinoma (ESCC) cells via suppression of PI3K\/AKT and Stat3 pathways","volume":"575","author":"Zhan","year":"2015","journal-title":"Archives of biochemistry and biophysics"},{"key":"33","doi-asserted-by":"crossref","first-page":"e97888","DOI":"10.1371\/journal.pone.0097888","article-title":"Pemetrexed induces S-phase arrest and apoptosis via a deregulated activation of Akt signaling pathway","volume":"9","author":"Chang","year":"2014","journal-title":"PloS one"},{"key":"34","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1111\/j.1742-4658.2006.05219.x","article-title":"Receptor association and tyrosine phosphorylation of S6 kinases","volume":"273","author":"Gout","year":"2006","journal-title":"The FEBS journal"},{"key":"35","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/0003-4975(94)90090-6","article-title":"Successful adenovirus-mediated gene transfer in anmodel of human malignant mesothelioma","volume":"57","author":"Albelda","year":"1994","journal-title":"The Annals of thoracic surgery"},{"key":"36","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1002\/ijc.29302","article-title":"ATF2 contributes to cisplatin resistance in non-small cell lung cancer and celastrol induces cisplatin resensitization through inhibition of JNK\/ATF2 pathway","volume":"136","author":"Scagliotti","year":"2015","journal-title":"International journal of cancer"},{"key":"37","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method","volume":"25","author":"Schmittgen","year":"2001","journal-title":"Methods"},{"key":"38","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1097\/JTO.0000000000000436","article-title":"Targeted next-generation sequencing of cancer genes in advanced stage malignant pleural mesothelioma: a retrospective study","volume":"10","author":"Scagliotti","year":"2015","journal-title":"Journal of thoracic oncology"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.10428","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,6]],"date-time":"2020-08-06T11:45:12Z","timestamp":1596714312000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.10428"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,6]]},"references-count":38,"journal-issue":{"issue":"47","published-print":{"date-parts":[[2016,11,22]]}},"alternative-id":["10428","27391433"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.10428","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,6]]}}}